Barbora Obermannová

1.3k total citations
54 papers, 800 citations indexed

About

Barbora Obermannová is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Barbora Obermannová has authored 54 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Endocrinology, Diabetes and Metabolism, 29 papers in Genetics and 16 papers in Surgery. Recurrent topics in Barbora Obermannová's work include Diabetes and associated disorders (18 papers), Diabetes Management and Research (16 papers) and Growth Hormone and Insulin-like Growth Factors (12 papers). Barbora Obermannová is often cited by papers focused on Diabetes and associated disorders (18 papers), Diabetes Management and Research (16 papers) and Growth Hormone and Insulin-like Growth Factors (12 papers). Barbora Obermannová collaborates with scholars based in Czechia, United Kingdom and United States. Barbora Obermannová's co-authors include Zdenĕk Šumnı́k, Stanislava Koloušková, Lenka Petruželková, Jan Lebl, Štěpánka Průhová, Ondřej Cinek, Petra Dušátková, Lukáš Plachý, Štěpánka Průhová and Vít Neuman and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Barbora Obermannová

48 papers receiving 779 citations

Peers

Countries citing papers authored by Barbora Obermannová

Since Specialization

Citations

This map shows the geographic impact of Barbora Obermannová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbora Obermannová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbora Obermannová more than expected).

Fields of papers citing papers by Barbora Obermannová

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbora Obermannová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbora Obermannová. The network helps show where Barbora Obermannová may publish in the future.

Co-authorship network of co-authors of Barbora Obermannová

This figure shows the co-authorship network connecting the top 25 collaborators of Barbora Obermannová. A scholar is included among the top collaborators of Barbora Obermannová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbora Obermannová. Barbora Obermannová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Longer, the Better: Continuous Glucose Monitoring Use for ≥90% Is Superior to 70%–89% in Achieving Tighter Glycemic Outcomes in Children with Type 1 Diabetes 2025 ·Diabetes Technology & Therapeutics ·(unknown), Vít Neuman, (unknown), (unknown), Markéta Pavlı́ková, (unknown), (unknown), David Neumann, (unknown), (unknown), Renata Pomahačová, (unknown), (unknown), Barbora Obermannová, Štěpánka Průhová, Ondřej Cinek, Zdenĕk Šumnı́k, (unknown)	1
2	Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study 2024 ·Diabetes Research and Clinical Practice ·Lukáš Plachý, Vít Neuman, (unknown), (unknown), (unknown), (unknown), Barbora Obermannová, Stanislava Koloušková, Štěpánka Průhová, Zdenĕk Šumnı́k, Lenka Petruželková	2
3	The Genetic Landscape of Children Born Small for Gestational Age with Persistent Short Stature 2023 ·Hormone Research in Paediatrics ·(unknown), Lukáš Plachý, Petra Dušátková, (unknown), Lenka Elblová, Zdenĕk Šumnı́k, (unknown), Marta Šnajderová, Barbora Obermannová, Štěpánka Průhová, Jan Lebl	14
4	Analysis of children with familial short stature: who should be indicated for genetic testing? 2023 ·Endocrine Connections ·Lukáš Plachý, Lenka Petruželková, Petra Dušátková, (unknown), D Zemková, Lenka Elblová, Vít Neuman, Stanislava Koloušková, Barbora Obermannová, Marta Šnajderová, Zdenĕk Šumnı́k, Jan Lebl, Štěpánka Průhová	6
5	Are all HCL systems the same? long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based study 2023 ·Frontiers in Endocrinology ·(unknown), Lukáš Plachý, Vít Neuman, Markéta Pavlı́ková, Lenka Petruželková, (unknown), (unknown), (unknown), Renata Pomahačová, David L. Neumann, (unknown), (unknown), (unknown), Barbora Obermannová, Štěpánka Průhová, Ondřej Cinek, Zdenĕk Šumnı́k	18
6	Glycemic Control by Treatment Modalities: National Registry-Based Population Data in Children and Adolescents with Type 1 Diabetes 2023 ·Hormone Research in Paediatrics ·Zdenĕk Šumnı́k, Markéta Pavlı́ková, Vít Neuman, Lenka Petruželková, (unknown), (unknown), (unknown), Renata Pomahačová, David L. Neumann, (unknown), (unknown), (unknown), Barbora Obermannová, (unknown), Lukáš Plachý, (unknown), Ondřej Cinek, (unknown)	8
7	Pre‐school and school‐aged children benefit from the switch from a sensor‐augmented pump to an AndroidAPS hybrid closed loop: A retrospective analysis 2021 ·Pediatric Diabetes ·Lenka Petruželková, (unknown), Jan Šoupal, (unknown), Lukáš Plachý, Vít Neuman, Štěpánka Průhová, Barbora Obermannová, Stanislava Koloušková, Zdenĕk Šumnı́k	31
8	Familial Short Stature—A Novel Phenotype of Growth Plate Collagenopathies 2021 ·The Journal of Clinical Endocrinology & Metabolism ·Lukáš Plachý, Petra Dušátková, (unknown), Lenka Petruželková, Lenka Elblová, Stanislava Koloušková, Marta Šnajderová, Barbora Obermannová, D Zemková, Zdenĕk Šumnı́k, Jan Lebl, Štěpánka Průhová	21
9	Hemoglobin A1c trajectories in the first 18 months after diabetes diagnosis in the SWEET diabetes registry 2021 ·Pediatric Diabetes ·Priya Prahalad, Anke Schwandt, Stéphane Besançon, (unknown), Barbora Obermannová, Melanie Kershaw, Riccardo Bonfanti, (unknown), Ragnar Hanås, Kristina Casteels, (unknown)	10
10	Papel de la PET/TC con 18F-DOPA en el diagnóstico de la forma congénita focal del hiperinsulinismo en niños 2020 ·Revista Española de Medicina Nuclear e Imagen Molecular ·(unknown), Jiří Trnka, (unknown), Barbora Obermannová, Lukáš Lambert	1
11	Screening of monogenic autoimmune diabetes among children with type 1 diabetes and multiple autoimmune diseases: is it worth doing? 2019 ·Journal of Pediatric Endocrinology and Metabolism ·(unknown), Lenka Elblová, Matthew B. Johnson, Petra Dušátková, Barbora Obermannová, Lenka Petruželková, Stanislava Koloušková, Marta Šnajderová, Eva Froňková, Michael Svatoň, Jan Lebl, Andrew T. Hattersley, Zdenĕk Šumnı́k, Štěpánka Průhová	6
12	High Prevalence of Growth Plate Gene Variants in Children With Familial Short Stature Treated With GH 2019 ·The Journal of Clinical Endocrinology & Metabolism ·Lukáš Plachý, (unknown), Lenka Elblová, Barbora Obermannová, Stanislava Koloušková, Marta Šnajderová, D Zemková, Petra Dušátková, Zdenĕk Šumnı́k, Jan Lebl, Štěpánka Průhová	49
13	Significant Prevalence of Severe Monogenic Immune Defects Among Children with Type 1 Diabetes and Low T1D-Genetic Risk Score 2018 ·Štěpánka Průhová, (unknown), Lenka Elblová, Matthew B. Johnson, Petra Dušátková, Barbora Obermannová, Lenka Petruželková, Stanislava Koloušková, Marta Šnajderová, (unknown), Michael Svatoň, Jan Lebl, Andrew T. Hattersley, Zdenĕk Šumnı́k	1
14	Excellent Glycemic Control Maintained by Open-Source Hybrid Closed-Loop AndroidAPS During and After Sustained Physical Activity 2018 ·Diabetes Technology & Therapeutics ·Lenka Petruželková, Jan Šoupal, (unknown), (unknown), Vít Neuman, Lukáš Plachý, Štěpánka Průhová, Zdenĕk Šumnı́k, Barbora Obermannová	51
15	Androgen production in pediatric adrenocortical tumors may occur via both the classic and/or the alternative backdoor pathway 2017 ·Molecular and Cellular Endocrinology ·Nesa Marti, Jana Malíková, José A. Galván, M.C. Aebischer, Marco Janner, Zdenĕk Šumnı́k, Barbora Obermannová, Geneviève Escher, Aurel Perren, Christa E. Flück	8
16	Alteration of B cell subsets and the receptor for B cell activating factor (BAFF) in paediatric patients with type 1 diabetes 2017 ·Immunology Letters ·Zuzana Paračková, Adam Klocperk, (unknown), Jana Kayserová, Irena Zentsová, Zdenĕk Šumnı́k, Stanislava Koloušková, (unknown), Štěpánka Průhová, Barbora Obermannová, Lenka Petruželková, Jan Lebl, Tomáš Kalina, Anna Šedivá	11
17	Novel calcium-sensing receptor cytoplasmic tail deletion mutation causing autosomal dominant hypocalcemia: molecular and clinical study 2016 ·European Journal of Endocrinology ·Barbora Obermannová, Zdenĕk Šumnı́k, Petra Dušátková, Ondřej Cinek, Michael P. Grant, Jan Lebl, Geoffrey N. Hendy	10
18	High Prevalence ofPROP1Defects in Lithuania: Phenotypic Findings in an Ethnically Homogenous Cohort of Patients With Multiple Pituitary Hormone Deficiency 2013 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Petra Dušátková, Barbora Obermannová, Roland Pfaeffle, Werner Blum, Dalia Adukauskienė, (unknown), Ondřej Cinek, Rasa Verkauskienė, Jan Lebl	19
19	Eosinophils from patients with type 1 diabetes mellitus express high level of myeloid alpha-defensins and myeloperoxidase 2012 ·Cellular Immunology ·Aleš Neuwirth, Jan Dobeš, (unknown), (unknown), Martina Benešová, Zdenĕk Šumnı́k, (unknown), Stanislava Koloušková, Barbora Obermannová, Michal Kolář, Kateřina Štechová, Dominik Filipp	22
20	HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes 2011 ·Journal of Pediatric Endocrinology and Metabolism ·Petra Dušátková, Štěpánka Průhová, Zdenĕk Šumnı́k, Stanislava Koloušková, Barbora Obermannová, Ondřej Cinek, Jan Lebl	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact